RxCelerate

RxCelerate is an out-sourced drug discovery and development company, founded in 2012, with a focus on working smarter. It has grown rapidly to become one of the leading providers of drug development services in the UK. RxCelerate operates a unique model, providing capabilities to discover and develop drugs for clients, designing as well as executing every aspect of the research and development plan. RxCelerate offers a wide range of services. The biology team specializes in in vivo pharmacology, offering proprietary models of a wide range of human diseases, as well as complex cell-based assays. The chemistry team provides medicinal chemistry, including in silico screening, and synthesis that integrates seamlessly with the in vitro testing capability, while the newly established RxBiologics team has launched Galaxy™, a next-generation antibody discovery platform. By working closely together, these teams can deliver pharma-grade drug product candidates at a fraction of the cost of traditional approaches. RxCelerate has a team of more than 60 employees and consultants based at the Babraham Research Campus, approximately five miles south of Cambridge, UK.